Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127193) titled 'Tofacitinib for Refractory Chronic Spontaneous Urticaria: Clinical Features, Treatment Response, and Predictors of Efficacy' on June 26.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Army Medical University
Condition:
Chronic spontaneous urticaria
Intervention:
Ineffective treatment group:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: Ineffective treatment group:28;Effective treatment group:56;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj...